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Abstract
Resistance to traditional antifungal drugs has increased significantly over the past three decades, making identification of
novel antifungal agents and new targets an emerging priority. Based on the extraordinary zinc requirement of several
fungal pathogens and their well-established sensitivity to zinc deprivation, we developed an efficient cell-based screen to
identify new antifungal drugs that target the zinc homeostasis machinery. The screen is based on the zinc-regulated
transcription factor Zap1 of Saccharomyces cerevisiae, which regulates transcription of genes like the high-affinity zinc
transporter ZRT1. We generated a genetically modified strain of S. cerevisae that reports intracellular zinc deficiency by
placing the coding sequence of green fluorescent protein (GFP) under the control of the Zap1-regulated ZRT1 promoter.
After showing that the GFP fluorescence signal correlates with low intracellular zinc concentrations in this strain, a protocol
was developed for screening small-molecule libraries for compounds that induce Zap1-dependent GFP expression.
Comparison of control compounds and known modulators of metal metabolism from the library reveals a robust screen
(Z9=0.74) and validates this approach to the discovery of new classes of antifungal compounds that interfere with the
intracellular zinc homeostasis. Given that growth of many pathogenic organisms is significantly impaired by zinc limitation;
these results identify new types of antifungal drugs that target critical nutrient acquisition pathways.
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Introduction
Candida species are pathogenic organisms that account for
most fungal infections in humans [1,2]. With emerging drug
resistance these pathogens have become a serious health
problem, especially in immune-compromised patients with
human immunodeficiency virus (HIV), chemotherapy patients,
or transplant recipients [3,4]. Despite intensive research only
three types of antifungal drugs are currently in clinical use for
systemic fungal infections. The first class targets enzymes of the
ergosterol biosynthesis pathway. Ergosterol is the major sterol of
the fungal plasma membrane and is important for its fluidity
and integrity and therefore for the proper function of
membrane-bound enzymes [5]. The second class, Echinocan-
dins, is used in severe cases of Candidiasis. They inhibit b-
glucan synthase and therefore interfere with cell wall biosyn-
thesis [6]. The last class of antifungal drugs are nucleoside
analogues such as 5-Flucytosine. This compound is imported
into the cell and modified like cytosine, which results in
production of 5-fluoro-UMP, a DNA synthesis inhibitor, and 5-
fluoro-UTP, which disrupts protein synthesis when incorporated
into RNA. However, the increasing resistance to these
antifungal drugs coupled with the increasing number of immune
compromised and AIDS patients makes it important to identify
novel antifungal agents and new targets. Since pathogenic
organisms require extraordinary concentrations of zinc and are
highly susceptible to zinc deprivation, we have turned our
attention to the high affinity pathways involved in zinc
acquisition and utilization.
Prior studies have shown that zinc is an essential micronutrient
for the proliferation of pathogenic organisms [7,8,9]. In fact, many
organisms are more susceptible to loss of zinc than to iron
deprivation [10]. The intracellular demand for zinc is quite high
within bacterial and eukaryotic cells, which maintain zinc
concentrations in the millimolar range. Despite this high total
intracellular zinc concentration, very few zinc ions are free or
weakly bound within the cell [11]. In eukaryotic cells those
millimolar concentrations of zinc ions are often found in
compartment, e.g. vacuoles [12], while concentration of free zinc
in the cytosol is estimated to be in the lower nanomolar range [13].
Moreover, several zinc transporters have been reported as
virulence factors in gram-negative and gram-positive bacteria as
well as eukaryotic pathogens [8,14,15,16]. Zinc transporter knock-
out mutants are no longer able to grow in a low zinc environment
and show reduced virulence. Given these observations, zinc
homeostasis pathways show promise as target for antifungal drugs.
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import, export, and redistribution are tightly regulated to maintain
a relatively constant intracellular zinc level [17]. The zinc
activated protein 1 (Zap1) is one factor that modulates expression
of gene products involved in zinc trafficking, such as the zinc
uptake transporter. Zap1 is a transcription factor that acts by
binding to zinc responsive elements (ZRE) of the promoter regions
of high affinity zinc regulated genes at high intracellular zinc, and
thus leading to the inhibition of gene transcription [18,19]. If
intracellular zinc level drop Zap1 loses its bound zinc and
transcription occurs. Recently, Zap1 orthologs have been reported
in Candida albicans and Aspergillus fumigatus suggesting that similar
zinc regulation circuits exist in these pathogenic fungi [20,21].
We describe here the development of a screen for new
antifungal agents that interfere with zinc homeostasis. To
accomplish this, we created a promoter-reporter construct by
fusing a 1 kb promoter fragment containing ZREs of the S.
cerevisiae high affinity zinc transporter ZRT1 to the sequence of
green fluorescent protein (GFP). GFP is used in various
biochemical applications like protein tagging, monitoring of gene
expression, imagine of protein-protein interaction but recently also
for drug screening purposes [22,23]. Successful screens for anti-
HIV drugs and chemopreventive agents using the promoter-GFP
strategy have been described, indicating that the proposed zinc
sensor might be able to detect new antifungal drugs targeting zinc
homeostasis proteins [24,25]. In this study we successfully
developed a zinc specific high-throughput drug screen. Our
analysis identified several compounds that interfere with zinc
homeostasis. Surprisingly, some of them did not alter total zinc
concentration but are likely to target intracellular sequestration
and distribution pathways.
Results
Yeast transformants report zinc status
In order to develop a high-throughput screen for agents that
disrupt zinc homeostasis we generated a yeast strain that expresses
GFP specifically under conditions of zinc deprivation. We
accomplished this by fusing the sequence of the promoter region
of the ZRT1 transporter gene with GFP. Previous studies have
shown that the Zap1 protein suppresses zinc-responsive gene
expression by binding to ZRE elements in target promoters
[17,18]. Therefore, genetically modified yeast cells expressing the
ZRE-GFP promoter-reporter construct serve as a zinc sensor
system. Under high and normal zinc concentrations GFP
expression is inhibited by Zap1 (Figure 1A). When zinc
concentration drops below a physiologically sufficient level GFP
expression occurs (Figure 1B).
We avoided plasmid copy number effects associated with
episomal expression by integrating the ZRE-GFP promoter-
reporter construct into the genome of the S. cerevisiae strain
DY1457. The response of this sensor strain to zinc deficiency was
then evaluated by growing cells in LZM medium containing a
range of zinc concentrations (1 mM to 1 mM). As expected,
expression of GFP was activated under low zinc conditions in cells
containing the zinc sensor construct (Figure 2A). We found that
GFP fluorescence intensity decreased logarithmically with increas-
ing zinc concentrations in the growth medium (Figure 2A inset).
The maximal GFP induction measured was 12-fold at 1 mM zinc
supplementation. No GFP fluorescence was observed in samples
grown in medium with 1 mM Zn. The fluorescence signal at this
condition is comparable to autofluorescence generated by
untransformed DY1457 cells.
Zinc sensor construct is specifically responsive to zinc
and not to other metals or cellular stress
In order to demonstrate that the promoter-reporter construct
only responses to changes in zinc concentration but not to other
metal ions we added solutions of 100 mM of zinc or various other
divalent metal ions to LZM already supplemented with 10 mM Zn.
As shown in Figure 2B, only the addition of zinc to the medium
results in a significant decrease in GFP expression while only small
changes in GFP fluorescence was observed with other metal ions.
This suggests metal specificity of this method.
We also investigated the responsiveness of the sensor to other
cellular stress conditions like heat and oxidative stress. Neither
heat treatment nor the addition of H2O2 resulted in an increase in
GFP expression (Figure S1). Moreover additional insights about
oxidative stress response were obtained from screening the small-
molecule Spectrum library. Redox active compounds included in
the library, like menadione, benzoyl peroxide or hydroquinone,
have been shown to generate reactive oxygen species (ROS);
however they do not increase GFP expression.
GFP expression increases after treatment with proof-of-
concept compounds
Next, we tested the performance of the zinc responsive reporter
strain with compounds known to interfere with zinc homeostasis,
including metal chelators. As expected, treatment with chelators
like EDTA, DTPA (Figure S2), and TPEN (Figure 3A) resulted in
increased GFP expression in a dose-dependent manner. Because
EDTA and DTPA are not cell permeable, this unsurprisingly
demonstrates that chelation of zinc in the extracellular medium
renders the metal unavailable for the cell and results in decreased
intracellular zinc concentration. TPEN, on the other hand, has a
higher affinity for zinc (log K=15.2 at pH 7.6) and can scavenge
zinc in the external medium as well as inside the cell [11]. It was
the most effective inducer of GFP expression among the proof-of-
concept compounds. A significant increase in GFP fluorescence
was observed at TPEN concentrations as low as 250 nM. GFP
expression further increased at higher concentration of TPEN
reaching a maximum at 5 mM. Thus, we used TPEN concentra-
tion of 5 mM as positive control in our efforts to identify
compounds that disrupt zinc homeostasis.
Figure 1. Model of zinc-regulated gene expression. A) Under
high or normal zinc conditions Zap1 binds zinc and blocks the ZRE
elements of the ZRT1 promoter and therefore inhibits GFP expression.
B) Under zinc deficient conditions Zap1 releases zinc then disassociates
from the ZRT1 promoter, which leads to the expression of GFP.
doi:10.1371/journal.pone.0025136.g001
Zinc-Dependent High-Throughput Screen
PLoS ONE | www.plosone.org 2 September 2011 | Volume 6 | Issue 9 | e25136GFP expression is time-dependent
Previous studies have shown that zinc accumulated in the yeast
vacuole can sustain growth for 6 to 8 doublings [12]. Since zinc
concentrations have to be sufficiently reduced in order to trigger
an increase in GFP expression, determining the optimal assay time
point was crucial. Therefore we treated cells with 5 mM TPEN
and compared GFP fluorescence and cell density relative to
untreated control every 2 hours. After 6 hours of incubation in
5 mM TPEN, we observed a 2-fold increase in fluorescence. The
maximum in GFP fluorescence for TPEN treated cells corre-
sponded to a 3-fold increase reached at 18 hours of incubation
(Figure 3B). Over this time, increase in GFP expression in control
cells was negligible.
The standard Z9 factor and signal to noise ratio for each time
point provide a direct evaluation of the robustness of this reporter
system for screening purposes (Table 1). Following established
approaches, the Z9 factor is defined as Z9=12((3s++3s2)/
(m+2m2)) [26]. In this study, s+ and s2 are the standard deviation
of GFP signal in positive control (TPEN) and negative control
(untreated sample), and m+ and m2 are the mean positive and
negative control signal. Most Z9 values shown in Table 1 were
above 0.5. The Z9 value of greater than 0.5 indicates that the
ZRE-GFP promoter-reporter construct is suitable for large scale
compound screening. The second assay robustness criteria is the
signal/noise ratio, which is defined as S/N=(m+2m2)/
((s+)
2+(s2)
2)
1/2 [27]. Numbers for this indicator should be high.
Figure 2. Zinc responsiveness of ZRE-GFP promoter-reporter construct. A) Comparison of Zn-dependent GFP fluorescence in
untransformed yeast cells (gray bars) and yeast transformed with the ZRE-GFP promoter-reporter construct (black bars). Cells were grown in LZM
medium with indicated zinc concentrations. GFP fluorescence and cell density were measured after 20 hours of incubation at 30uC. The inset shows a
power law fit through the data. The excellent quality of the fit (the linear correlation coefficient between the fluorescence and the zinc concentration
to the power 20.372 is R=0.993) indicates that the fluorescence decreases with increasing zinc concentration in a scale-free manner. B) Metal
specificity of the promoter-reporter construct. Transformed cells were grown in LZM either without (black bars) or with 100 mM (gray bars) of
indicated metal ions and analyzed as before. GFP fluorescence is expressed as percent of non-supplemented control. The fluorescence signal was
always normalized by cell density. Error bars represent standard deviation (SD).
doi:10.1371/journal.pone.0025136.g002
Figure 3. Dose and time response of GFP fluorescence after treatment with TPEN. A) Cells transformed with the ZRE-GFP promoter-
reporter construct were grown in RPMI-1640 medium with indicated TPEN concentrations for 20 hours at 30uC. Fluorescence signal was normalized
by cell density and is expressed as x-fold increase of untreated sample. B) Cells containing the ZRE-GFP promoter-reporter construct were grown in
absence or presence of 5 mM TPEN in RPMI-1640 medium at 30uC. Fluorescence and cell density were measured at times indicated. Fluorescence
signal is expressed as x-fold increase of the 0 hour time point. Error bars represent standard deviation (SD).
doi:10.1371/journal.pone.0025136.g003
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demonstrating again that this is an excellent assay. According to
these criteria time points of 18 and 20 hours were optimal. We
therefore measured GFP fluorescence and cell density after
20 hours for all high-throughput screens.
Screening of a small-molecule library
Having defined optimal assay conditions for the ZRE-GFP
promoter-reporter construct, we screened the Spectrum Collection
library, a small-molecule library of 2000 compounds. These
compounds were preselected to cover a wide range of biological
activities and structural features. Half of the compounds are drugs
with defined pharmacological and toxicological profiles, and the
remainder are natural products (30%) and bioactive compounds
like enzyme inhibitors or receptor blockers (20%). We assayed
compounds in duplicate at a single concentration of 100 mM. The
reproducibility of the screen is shown in Figure 4, where hit
correlation between two separate screen plates is linear (R=0.94)
indicating that the screen results were highly reproducible. We
defined compounds that induced GFP expression more than 1.5-
fold or 30%, respectively, of negative control as candidates for
further analysis. Approximately 4% of the compounds (80
compounds) inhibited growth completely at 100 mM and were
serially diluted and rescreened in two-fold dilutions steps between
100 mM and 0.19 mM. We refer to this set as Group A (Figure 5).
After examining ZRE-GFP induction at lower compound
concentrations, we found that only one third of these compounds
meet the criteria of being a hit. This indicates that cell toxicity in
general does not trigger ZRE-GFP expression and is consistent
with our earlier finding that other cellular stresses do not induce
Zap1-dependent GFP expression. GFP-inducing compounds that
allowed growth at 100 mM are classified as Group B. In total there
were 103 reproducible hits (5.15%) with 78 hits (3.9%) derived
from Group B and another 25 (1.25%) from Group A. A list of all
compounds identified can be found in Table S1. We organized
compounds of both groups in 3 categories according to the
magnitude of GFP induction in comparison to negative control
(category 1: .80%, category 2: 50–80% and category 3: 30–50%).
All compounds of group A induced GFP expression between 30–
80% only. Taken both groups A and B together a total of 34 and
63 compounds were found in the categories 2 and 3, respectively.
Six category 1 compounds with high GFP fluorescence were found
in Group B.
Validation of selected hit compounds
Even though stress or cell toxicity did not affect GFP expression
we wanted to determine if other secondary effects could trigger an
increase in GFP signal. Therefore, we developed a series of
validation experiments for commercial available compounds in the
top 30% of categories 1 and 2 in group B hits. In order to
determine if increased ZRE-GFP expression was indeed caused by
Table 1. Summary of robustness criteria of the promoter-
reporter assay.
Time
point (h)
TPEN GFP vs. untreated
control GFP (x-fold) Z9 value
Signal/
Noise
6 2.01 0.3 5.99
8 2.18 0.74 16.07
10 1.95 0.67 12.65
12 2.03 0.31 5.75
14 2.15 0.91 35.88
16 2.25 0.68 13.24
18 2.34 0.79 17.06
20 2.28 0.74 15.19
22 2.25 0.61 10.75
24 2.22 0.65 8.68
doi:10.1371/journal.pone.0025136.t001
Figure 4. Screen results are reproducible. The GFP intensities of
replica plate sets of screen 1 and screen 2 were plotted against each
other. The linear regression between both plate sets demonstrates
reproducibility of hit compounds. The cut off level for hit selection is
1.5-fold. The red box shows hits with high GFP induction level.
doi:10.1371/journal.pone.0025136.g004
Figure 5. Summary of screen results. 3.9% of all screened
compounds showed GFP induction at 100 mM concentration (group
B). Compounds that proved cytotoxic at 100 mM (4%) were serially
diluted and reanalyzed (group A). Positive hits of both groups were
categorized into classes according to their degree of GFP induction.
Category 1 hits showed induction of 80% and higher. For categories 2
and 3 GFP induction was 50%–80% and 30%–50%, respectively. The
percentage and number of compounds (in brackets) are shown for each
class and category.
doi:10.1371/journal.pone.0025136.g005
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selected primary hit compounds and stained them with the zinc
fluorescent probe Zinbo-5. The affinity of this probe for zinc
(Kd=2.2*10
29 M) is lower than that of most zinc-binding
proteins, and thus it only reports the free or weakly bound zinc
ions [28]. We then analyzed Zinbo-5 stained cells by flow
cytometry where dead cells were identified by propidium iodide
staining and excluded from the assay. In this analysis, Zinbo-5
fluorescence emission at 463 nm is indicative of labile zinc ions. As
control compounds, we analyzed the effects of the metal chelator
EDTA and the ionophore Zn-pyrithione. EDTA binds zinc with a
high affinity (log K=14.3) [29] and growth in EDTA-containing
medium (500 nM) leads to significantly lower accumulation of
intracellular zinc (0.9 nmol/mg dry weight). This corresponds to a
50% reduction relative zinc content of cells grown in the absence
of EDTA (1.76 nmol/mg dry weight), whereas growth in medium
containing Zn-pyrithione increases intracellular zinc level [30]. As
expected, we found that EDTA treatment resulted in low Zinbo-5
fluorescence but high GFP fluorescence, while Zn-pyrithione
treatment led to high Zinbo-5 fluorescence and low GFP
fluorescence (Figure 6).
We found that the intensity of Zinbo-5 and GFP fluorescence
were inversely related for most compounds tested. For these
compounds, we therefore conclude that the observed increased
ZRE-GFP expression can be explained by a decrease in labile
intracellular zinc. Intriguingly, we found that tolnaftate and b-
estradiol caused increased ZRE-GFP expression as well as Zinbo-5
fluorescence. Whereas no link between zinc homeostasis and
tolnaftate is known, b-estradiol has been shown to alter zinc
transporter activity and increase zinc plasma level [31,32].
Although more compounds will be validated, the results to date
are highly encouraging that most small molecules identified as hits
in the high-throughput screen interfere indeed with zinc
homeostasis.
Analyzing identified drug leads in Candida albicans
We have shown that the ZRE-GFP promoter-reporter construct
was able to identify agents that interfere with zinc homeostasis in
the non-pathogenic yeast S. cerevisiae. Next we evaluated the
activity of the most promising hits in the pathogenic yeast Candida
albicans. These agents were analyzed for dose dependent effects on
cell viability, labile zinc (determined by Zinbo-5 as described
above) and total zinc accumulation (measured by ICP-MS
analysis). Since Candida is polymorphic yeast we also looked at its
cell morphology after treatment with drug leads by light
microscopy. Cell morphology, total and labile zinc content after
atovaquone, halofantrine, and disulfiram treatment in Candida are
shown in Figure 7. Atovaquone-treated Candida cells showed a
striking increase in total zinc content but a decrease in labile zinc
level (Figure 7A). These findings are consistent with an extreme
disruption of zinc homeostasis. Li et al. reported a similar effect
with clioquinol, a known antifungal agent. In that study, yeast
treated with the clioquinol showed gene expression pattern of a
metal deficient cell even though total metal ion levels were
increased [33]. This was explained by a delivery of metals near
the plasma membrane where they are unavailable for most
metalloproteins.
Our results support the idea that zinc availability is generally
limited in Candida and that atovaquone is a modulator of zinc
homeostasis. Halofantrine also showed a decrease in labile zinc
while total zinc concentration was unchanged (Figure 7C). Further
increase in halofantrine concentration in Candida cultures resulted
in total growth inhibition (data not shown).
Total and labile zinc concentrations seemed to be unchanged in
Candida cells treated with disulfiram (Figure 7E) even though it is
an inducer of ZRE-GFP expression. Whereas Candida cell treated
with 25 mM atovaquone and halofantrine appear mainly in its
yeast form (Figure 7B, D), disulfiram triggers hyphae formation in
Candida (Figure 7F). This interferes with the consistency of flow
cytometry data due to the infinite number of cell shapes and sizes.
Therefore the demand for zinc in both forms could be significantly
altered and the comparison of zinc concentrations in an untreated
control in the yeast form with a disulfiram-treated sample in
hyphae form might lead to artifacts.
Discussion
In this study we describe the development and validation of a
high-throughput screen for antifungal drugs targeting zinc
homeostasis. The induction of a GFP signal driven by the
promoter of a zinc-responsive gene in live S. cerevisiae cells provides
a simple system to monitor changes in intracellular zinc
availability. In contrast to many other high-throughput assays this
is not a cytotoxicity screen. The assay not only reports on the
ability of a candidate agent to inhibit growth, it also looks at a
biological impact of that agent on key physiological pathways,
namely those involved in zinc homeostasis. With proper controls
and secondary assays, this dual index screen provides insights into
mechanism of action of the hits. Furthermore, instead of
measuring a decrease in zinc we analyze the amplification of a
physiologically regulated fluorescence signal. Measuring a positive
event abolishes artifacts or false positives caused by measuring too
close to low sensitivity thresholds. This assay was optimized for
high-throughput screens and due to its non-invasive nature is fast,
easy, and inexpensive to perform. Moreover, this screen is not
limited to an end point read-out. Since no staining or washing
steps are required, it is compatible with time course experiments.
The differences in GFP signals between negative (untreated
sample) and positive control (5 mMT P E N )r e s u l t e di naZ 9 value
of greater than 0.6. High sensitivity, good signal-to-noise ratio,
and reproducibility further demonstrate the potential of this
screen. The yeast-based live cell system selectively and
Figure 6. Validation of selected hits. A subset of hit compounds
was subjected to flow cytometry analysis. Cells were treated with hit
compounds and incubated for 20 hours at 30uC. Labile zinc content
was measured using the zinc fluorescent probe Zinbo-5. Zinbo-5
fluorescence was plotted in comparison to GFP fluorescence.
doi:10.1371/journal.pone.0025136.g006
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that interfere with zinc homeostasis. As far as we are aware, this
screen assay is the first designed to find hits throughout a
metabolic pathway as opposed to a particular target protein.
This increased the chances of identifying novel antifungals and
new core structures.
Hits can be categorized according to their degree of GFP
induction. Those with high GFP expression were put through
validation tests using a small molecule fluorescent probe (i.e. the
Zinbo-5 assay) to independently probe intracellular zinc availabil-
ity in parallel with GFP expression [28]. A total of 80% of hit
compounds tested showed an inverse correlation between GFP
Figure 7. Total and labile zinc and cell morphology of C. albicans. Candida cells treated with A, B) Atovaquone, C, D) Halofantrine or E, F)
Disulfiram and incubated at 30uC for 20 hours. 100 ml aliquots were immediately used for flow cytometry, the remaining culture was used for ICP-MS
analysis. Light microscopy images were obtained from cells treated with 25 mM atavaquone and halofantrine and 1 mM disulfiram using standard
protocols. Error bars represent standard deviation (SD). Level of significance are characterized as followed (* P,0.01, ** P,0.001, *** P,0.0001, not
significant P.0.05). Statistical significance was tested by one-way ANOVA.
doi:10.1371/journal.pone.0025136.g007
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cells, the ZRE-GFP promoter-reporter construct is able to identify
compounds that interfere with zinc homeostasis. Zap1 has been
shown to induce genes involved in oxidative stress or general cell
stress response. However a zinc-independent Zap1 activation has
so far not been described [34]. Moreover heat and oxidative stress
do not increase GFP expression.
As for most cell based assays, this zinc reporter screen does not
provide direct identification of the targets of these interesting new
hits. Additional studies support the idea that antifungal drug leads
identified in our zinc screen can target different mechanisms in
zinc homeostasis (Figure 8). Some leads may work as zinc
sequestering or chelating agents, which bind zinc in a form that
prevents transport from the surrounding media into the cell, or
they could bind intracellular zinc and make it unavailable to zinc-
dependent metalloenzymes. The hits may also function as
inhibitors of high affinity zinc uptake proteins or they could
inhibit intracellular zinc trafficking and sensing proteins, i.e.
vesicular zinc transporters, chaperones and transcription factors.
The results described here are consistent with a model wherein
atovaquone and halofantrine act as intracellular sequestering
agents. They allow uptake of zinc into the cell but prevent access
by zinc metalloproteins. Especially atovaquone might induce zinc
deficiency perhaps by effectively interfering with zinc binding to
Zap1, and therefore activating transcription of zinc uptake
proteins and triggering an elevated zinc uptake from the external
medium. Actual total and labile zinc level after disulfiram were
more difficult to determine due to the morphological difference in
comparison to untreated control cells. It is therefore not clear to
which category of action mechanism this drug belongs. Most
published data suggest that hyphae formation is triggered by zinc
deficiency [35,36,37].
One additional concern may be the selective targeting of human
rather than fungal proteins by hit compounds. To address this
issue we performed extensive bioinformatic analysis to compare
fungal and human Zip and CDF zinc transporter sequences. The
results are summarized in Table S2 and Figure S3. In general,
only little homology between fungal and human transporter
sequences could be found. Moreover, we looked at conserved
sequence motifs in both groups of zinc transporters. Whereas no
common sequence motif could be found between fungal and
human transporters of the Zip family, a HG/HS motif was shown
in both fungal and human CDF zinc transporters. This functional
motif, however, varies sufficiently in length and spacer amino acids
that selective targeting is possible. Hit compounds that interact
stronger with human proteins can easily be detected and
eliminated by testing and comparing their toxicity between fungi
and human cells; e.g. the effective concentration in Candida for
atovaquone is 4 to 10 times lower than the approved maximal
plasma concentration in human.
Taking all those observations in account, this zinc sensor screen
system provides the first step in identifying new targets for
antifungal agent that interfere with zinc homeostasis pathways.
Coupled with other methods (e.g. confocal microscopy) this screen
can identify mechanisms of action for lead compounds. We
anticipate that results obtained in the S. cerevisiae screening system
will apply to similar pathways in pathogenic yeast like Candida
albicans and Aspergillus spp.
Materials and Methods
Strains and growth conditions
The S. cerevisiae strain used is DY1457 (MATa ade6 can1 his3 leu2
trp1 ura3). Yeast precultures were grown in YP medium plus 2%
glucose (YPD) at 30uC. Transformants were plated on synthetic
defined medium plus 2% glucose (SD) and histidine was omitted for
plasmid selection. Initial GFP assays were carried out in low zinc
medium (LZM) at 30uC [17]. GFP proof of concept experiments and
high-throughput screens were performed at 30uC in RPMI-1640
medium without phenol red (R8755, Sigma-Aldrich, St. Louis, MO).
Phenol red was omitted because it interfered with GFP reading. The
medium was adjusted to pH 7.0. For heat shock experiments, cells
Figure 8. Summary of mode of action. The cell model shows the four potential mechanisms of action for hit compounds to interfere with zinc
homeostasis. Hit compounds can inhibit zinc uptake transporter, induce the formation of chelators or act as chelators themselves, interfere with zinc
transport in or out of compartments, or modulate zinc transcription factors like Zap1.
doi:10.1371/journal.pone.0025136.g008
Zinc-Dependent High-Throughput Screen
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incubation temperature was increase to 42uC for 10, 20 and
30 minute. Oxidative stress was applied by adding 0.1, 0.5 and
1m M o f H 2O2 to yeast cultures at OD600=0.5. All cloning
procedures were carried out in the Escherichia coli strain Top10F9
(Invitrogen, Carlsbad, CA). E. coli cells were grown in LB medium at
37uC with or without ampicillin. The Candida albicans strain 90028
was purchased from ATCC and grown in RPMI-1640 medium at
30uC for all experiments.
Constructions of promoter-reporter construct
Standard molecular biology procedures were used for DNA
manipulation and E. coli and yeast transformations [38,39]. GFP
sequence was amplified by polymerase chain reaction from
phMGFP (Promega, Madison, WI) using the primer CGCG
GGA TCC ATG GGC GTG ATC AAG CCC GAC and CGCG
GCG GCC GC TTA GCC GGC CTG GCG GGG TAG
containing a BamHI and NotI restriction site (underlined),
respectively. For the amplification of the ZRT1 promoter sequence
genomic DNA of S. cerevisiae was extracted and used as template
for PCR with the following primers CGCG CTC GAG TCA
GAT ATT TCT TTT TTT GTC CCT and CGCG GGA TCC
AAT TCC TTT TTT GAT ATT TGT GCT GTT containing a
XhoI and BamHI restriction site. Both PCR products were digested
with the appropriate restriction enzymes and ligated into the
similarly digested plasmid pRS303 (ATCC, Manassas, VA) to fuse
the ZRT1 promoter with GFP. The resulting plasmid was
linearized with PstI for integration at the chromosomal HIS3
locus of DY1457. Transformants were plated on SD plates minus
histidine for selection and positive transformants were selected for
subsequent experiments.
Validation of ZRE-GFP promoter-reporter assay
S. cerevisiae cells with integrated promoter-reporter construct
were inoculated in LZM with different zinc concentrations at a
starting cell density OD600=0.05. Cell suspension was transferred
to 96-well black clear-bottom microplates (Costar, Cat. No 3603).
After plates were filled they were sealed with AirPore tape
(Qiagen, Cat. No. 19571) and incubated with vigorous shaking at
30uC. Following overnight incubation GFP fluorescence data
(excitation 485/20 nm, emission 528/20 nm) were collected using
an automated plate reader Synergy2 (BioTek). To correct for cell
number variation in detection path due to non-uniform distribu-
tion of cells absorbance (OD600) was recorded for each well. The
fluorescence read-out was then divided by the absorbance reading.
All proof of concept experiments were performed in RPMI-1640
medium without phenol red. Compounds were dissolved in
DMSO (Sigma-Aldrich, St. Louis, MO) and serially diluted. 2 ml
of compound was pipetted to the wells of 96-well plates and 198 ml
cell suspension adjusted to OD600=0.05 was added.
High-throughput screen
The high-throughput screen was performed using liquid
handling robots. A small-molecule library of 2000 compounds
(Spectrum collection, MicroSource Discovery Systems, http://
www.msdiscovery.com/spectrum.html) in DMSO (stock concen-
tration 10 mM) was obtained. Two microliter of each solution
were transferred to 96-well black clear-bottom microplates
(Greiner, Cat No. 655090) using a Biomek FX 96 Multichannel
robot (Beckman Coulter, Brea, CA). Immediately 200 ml cell
suspension adjusted to OD600=0.05 in RPMI-1460 medium
without phenol red was added to the plates using a Titan Stacker-
Multidrop device (Titertek, Huntsville, AL). A negative (DMSO
blank) and a positive control (5 mM TPEN) was included in each
plate. Initial cell density and GFP fluorescence were measured
after filling the plates. Plates were then sealed with Airpore tape
(Qiagen, Cat. No. 19571) and incubated for 20 hours at 30uCi na
HiGro shaker-incubator (GeneMachines, Genomic Solutions, San
Carlos, CA). GFP fluorescence (excitation 485 nm, emission
528 nm) and cell density by OD at 600 nm were measured using
a plate reader Analyst GT (Molecular Devices, Sunnyvale, CA).
Compounds that proved to be excessively cytotoxic to yeast at the
initial concentration of 100 mM were retested at a lower
concentration. All compounds were serially diluted in DMSO
using a Biomek FX Span-8 robot (Beckman Coulter, Brea, CA).
Flow cytometry
Yeast cells from an overnight culture were adjusted to a density of
OD600=0.05 in RPMI-1460 medium and treated with selected hit
compounds identified in the high-throughput screen. After 20 hours
of incubation at 30uC with shaking 100 mla l iq u o t so fc e llc u l t u r ew e re
transferred into flow cytometry tubes (Falcon, Cat No. 352054). 1 ml
of a 1 mM stock solution of the zinc fluorescent probe Zinbo-5 was
added and incubated for an additional30 minutes at 30uC[ 2 8 ] .A f t e r
diluting the cell suspension with 500 ml of PBS buffer 5 ml propidium
iodide (500 mg/ml) was added for live/dead cell staining. Zinc
fluorescence was then analyzed (excitation 358 nm, emission
463 nm) using the BD LSRII flow cytometer (Becton Dickinson,
FranklinLakes,NJ).Data for live/dead cell staining wereobtained by
excitation at 538 nm and emission at 617 nm.
ICP-MS measurements
Cells were grown for 20 hours with a starting density of
OD600=0.05 in RPMI-1460 medium with or without treatment.
Cells were harvested by centrifugation at 10006g for 5 minutes
and then washed in ice-cold distilled deionized water. After cell
pellet was frozen it was freeze-dried for several hours. The dry
pellet was digested in 200 ml 65% HNO3 at 90uC for 30 minutes.
The digest was filled up to a total volume of 5 ml with distilled
deionized water and internal standard and immediately used for
ICP-MS analysis (X-Series 2 ICP-MS, Thermo Fisher Scientific).
Supporting Information
Figure S1 GFP expression after oxidative and heat stress
treatment. Cells transformed with the ZRE-GFP promoter-
reporter construct were grown in RPMI-1640 medium at 30uC
to a cell density of 0.5. A) Oxidative stress was applied by adding
0.5 mM of H2O2. Cells treated with 5 mM TPEN were used as
positive control. Cells continued to grow for 10, 30 and 60 minutes
and GFP fluorescence and cell density was measured. B) Cells
were quickly transferred from 30uC to a prewarmed 50 ml-falcon
tube in a 42uC water bath. After cells were incubated at this
temperature for 10, 20 and 30 minutes, GFP fluorescence and cell
density was determined. Cells treated with 5 mM TPEN were used
as positive control. Error bars represent standard deviation (SD).
(TIF)
Figure S2 Dose response of GFP fluorescence after treatment
with DTPA and EDTA. Cells transformed with the ZRE-GFP
promoter-reporter construct were grown in RPMI-1640 medium
with indicated chelator concentrations for 20 hours at 30uC.
Fluorescence signal was normalized by cell density and is
expressed as x-fold increase of untreated sample. Error bars
represent standard deviation (SD).
(TIF)
Figure S3 Motif comparison of Zinc transporters. Human and
fungal zinc transporters of the Zip family (A) and CDF family (B)
Zinc-Dependent High-Throughput Screen
PLoS ONE | www.plosone.org 8 September 2011 | Volume 6 | Issue 9 | e25136were analyzed for conserved functional motifs. Motifs of human
CDF and Zip group I transporter are shown in red, hZip group II
in blue and fungal transporters in green. TMpred and ClustalW2
were used for motif analysis.
(TIF)
Table S1 Summary of Hit Compounds.
(PDF)
Table S2 Protein sequence comparison between human and
fungal A) Zip and B) CDF transporters.
(PDF)
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